{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:27:58Z","timestamp":1785425278016,"version":"3.56.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Amgen Cardiovascular"},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boehringer Ingelheim"},{"name":"Boston Scientific"},{"name":"The Bristol Myers Squibb and Pfizer Alliance"},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company"},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Menarini Int. Op"},{"name":"MSD-Merck & Co"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanofi"},{"DOI":"10.13039\/501100011725","name":"SERVIER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vifor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To determine the current state of the use of reperfusion and adjunctive therapies and in-hospital outcomes in European Society of Cardiology (ESC) member and affiliated countries for patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>ESC EurObservational Research Programme prospective international cohort study of admissions with STEMI within 24\u2005h of symptom onset (196 centres; 26 ESC member and 3 affiliated countries). Of 11\u2009462 patients enrolled, 448 (3.9%) had CS. Patients with compared to patients without CS, less frequently received primary percutaneous coronary intervention (PCI) (65.5% vs. 72.2%) and fibrinolysis (15.9% vs. 19.0), and more often had no reperfusion therapy (19.0% vs. 8.5%). Mechanical support devices (intraaortic ballon pump 11.2%, extracoporeal membrane oxygenation 0.7%, other 1.1%) were used infrequently in CS. Bleeding definition academic research consortium 2\u20135 bleeding complications (10.1% vs. 3.0%, P\u2009&amp;lt;\u20090.01) and stroke (4.2% vs. 0.9%, P\u2009&amp;lt;\u20090.01) occurred more frequently in patients with CS. In-hospital mortality was 10-fold higher (35.5% vs. 3.1%) in patients with CS. Mortality in patients with CS in the groups with PCI, fibrinolysis, and no reperfusion therapy were 27.4%, 36.6%, and 62.4%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this multi-national registry, patients with STEMI complicated by CS less frequently receive reperfusion therapy than patients with STEMI without CS. Early mortality in patients with CS not treated with primary PCI is very high. Therefore, strategies to improve clinical outcome in STEMI with CS are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjacc\/zuac049","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T19:23:07Z","timestamp":1650396187000},"page":"481-490","source":"Crossref","is-referenced-by-count":4,"title":["Reperfusion therapy for ST-elevation myocardial infarction complicated by cardiogenic shock: the European Society of Cardiology EurObservational programme acute cardiovascular care-European association of PCI ST-elevation myocardial infarction registry"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-283X","authenticated-orcid":false,"given":"Uwe","family":"Zeymer","sequence":"first","affiliation":[{"name":"Klinikum der Stadt Ludwigshafen and Institut f\u00fcr Herzinfarktforschung , Ludwigshafen am Rhein , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ludman","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en G. Pompidou, Service de Cardiologie , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kala","sequence":"additional","affiliation":[{"name":"Internal Cardiology Department, Faculty of Medicine of Masaryk University, University Hospital Brno , Brno , Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Program, European Society of Cardiology , Sophia-Antipolis , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Program, European Society of Cardiology , Sophia-Antipolis , France"},{"name":"Maria Cecilia Hospital, GVM Care & Research , Cotignola , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Siabani","sequence":"additional","affiliation":[{"name":"Kermanshah University of Medical Sciences , Kermanshah , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences , Isfahan , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Wafa","sequence":"additional","affiliation":[{"name":"Mansoura Faculty of Medicine, Cardiology department , Mansoura , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw","family":"Bartus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jagiellonian University , Krakow , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Weidinger","sequence":"additional","affiliation":[{"name":"Hospital Rudolfstiftung , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"2022062217485317900_zuac049-B1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2048872619894254","article-title":"Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology","volume":"9","author":"Zeymer","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022062217485317900_zuac049-B2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B3","article-title":"2017 ESC guidelines on the management of acute myocardial infarction in patients presenting with ST-segment elevation","author":"Ibanez","year":"2017","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N Engl J Med"},{"key":"2022062217485317900_zuac049-B5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","article-title":"Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-elevation Myocardial Infarction) 1995 to 2015","volume":"136","author":"Puymirat","year":"2017","journal-title":"Circulation"},{"key":"2022062217485317900_zuac049-B6","doi-asserted-by":"crossref","first-page":"T87","DOI":"10.4244\/EIJV10STA14","article-title":"Stent for life initiative: leading example in building STEMI systems of care in emerging countries","author":"Kaifoszova","year":"2014","journal-title":"EuroIntervention"},{"key":"2022062217485317900_zuac049-B7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","article-title":"A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europ and the Mediterran basin: the Euro Heart Survey on Acute Coronary Syndromes (Euro Heart Survey ACS)","volume":"23","author":"Hasdai","year":"2002","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B8","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B9","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1093\/eurheartj\/ehq305","article-title":"Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction","volume":"31","author":"Schiele","year":"2010","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/2048872613497341","article-title":"Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries","volume":"2","author":"Puymirat","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022062217485317900_zuac049-B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2048872617745008","article-title":"Background and design of the ACCA-EAPCI registry on ST-segment elevation myocardial infarction of the European Society of Cardiology","volume":"8","author":"Zeymer","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022062217485317900_zuac049-B12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ehjqcco\/qcz042","article-title":"The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry","volume":"6","author":"Zeymer","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2022062217485317900_zuac049-B13","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2022062217485317900_zuac049-B14","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1093\/eurheartj\/ehab342","article-title":"Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the Association for Acute cardiovascular Care-European Association for Percutaneous coronary intervention (ACVC-EAPCI) EORP STEMI Registry of the European Society of Cardiology","volume":"42","author":"Zeymer","year":"2021","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2022062217485317900_zuac049-B16","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"2022062217485317900_zuac049-B17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"STREAM investigative team fibrinolysis or primary PCI in ST-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N Engl J Med"},{"key":"2022062217485317900_zuac049-B18","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"2022062217485317900_zuac049-B19","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/eurheartj\/ehs264","article-title":"Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries","volume":"33","author":"Aissaoui","year":"2012","journal-title":"Eur Heart J"},{"key":"2022062217485317900_zuac049-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.athoracsur.2008.03.019","article-title":"Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease","volume":"86","author":"Lee","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2022062217485317900_zuac049-B21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ehj.2003.12.008","article-title":"Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhaus\u00e4rzte (ALKK)","volume":"25","author":"Zeymer","year":"2004","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/11\/6\/481\/44171369\/zuac049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/11\/6\/481\/44171369\/zuac049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T17:49:44Z","timestamp":1655920184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/11\/6\/481\/6589609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,5,20]]},"published-print":{"date-parts":[[2022,6,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuac049","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,5,20]]}}}